Literature DB >> 16732464

Duloxetine for childhood depression with pain and dissociative symptoms.

Pushpal Desarkar1, Anindya Das, Vinod K Sinha.   

Abstract

Over two thirds of people suffering from depression complain of pain with or without reporting psychological symptoms. Physical symptoms are more prevalent among the women, the elderly, the poor, and in children population. Successful treatment of depression in children complicated by pain symptoms constitutes a great clinical challenge. Duloxetine has already emerged as a safe and effective treatment option for adult depressed patients with painful physical symptoms. However, no data exist in literature which suggests use of duloxetine in childhood and adolescent population for the same clinical indication. We report a case documenting successful use of duloxetine in a depressed girl child who also had severe pain and dissociative symptoms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16732464     DOI: 10.1007/s00787-006-0553-4

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  9 in total

Review 1.  Venlafaxine: a new class of antidepressant.

Authors:  Julia Hardy; Spilios Argyropoulos; David J Nutt
Journal:  Hosp Med       Date:  2002-09

2.  Duloxetine for pain symptoms in patients with major depressive disorder.

Authors:  Prakash S Masand; Rajnish Mago
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

Review 3.  [Depression and pain: novel clinical, neurobiological and psychopharmacological data].

Authors:  Jan Jaracz; Janusz Rybakowski
Journal:  Psychiatr Pol       Date:  2005 Sep-Oct       Impact factor: 1.657

4.  Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

Authors:  David J Goldstein; Craig Mallinckrodt; Yili Lu; Mark A Demitrack
Journal:  J Clin Psychiatry       Date:  2002-03       Impact factor: 4.384

5.  Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study.

Authors:  John V Campo; James Perel; Amanda Lucas; Jeff Bridge; Mary Ehmann; Catherine Kalas; Kelly Monk; David Axelson; Boris Birmaher; Neal Ryan; Carlo Di Lorenzo; David A Brent
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-10       Impact factor: 8.829

Review 6.  Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.

Authors:  Alan F Schatzberg
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

Review 7.  Common pathways of depression and pain.

Authors:  Pedro L Delgado
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

Review 8.  Physical symptoms of depression: unmet needs in special populations.

Authors:  Donna E Stewart
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

Review 9.  Presentation and course of major depressive disorder during childhood and later years of the life span.

Authors:  M Kovacs
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 8.829

  9 in total
  1 in total

1.  Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescent.

Authors:  Ludmyla Kachko; Shiri Ben Ami; Alon Liberman; Einat Birk; Sefi Kronenberg
Journal:  Pain Res Manag       Date:  2011 Nov-Dec       Impact factor: 3.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.